Lecture 1: Inflammation I Flashcards

1
Q

Types of inflammation

A
  1. Acute (0-7 days)
  2. Subacute (7-30 days)
  3. Chronic (30+ days)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inflammation

A

Host response to injury or insult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of leukocytes (WBCs)

A
  1. Granulocytes (PMNs, eosinophils, basophils)
  2. Lymphocytes (T, B, NK)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of T cells

A
  1. CD4+ T
    - Th1: pro-inflam.; IL-1/6, TNF, IFNγ
    - Th2: IL-4/5/13
    - Th17: recruit PMNs, IL-17
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Other inflammatory cells

A
  • Monocytes/macrophages
  • APCs
  • Fibroblasts (scarring)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

M1 vs M2 macrophages

A

Aka classical vs alternative activation; microbicidal vs remodeling/repair
M1: ROS, NO, lysozymes, pro-inflam. (IL-1/6/12)
M2: fibrosis, repair, anti-inflam. (IL-10, TGFβ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cell-derived acute inflam. molecules

A

Preformed in storage granules or synthesized rapidly de novo
- Histamine
- Prostaglandins
- Cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Plasma protein-derived acute inflam. molecules

A

Complement molecules; mainly formed by liver, present in inactive form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cardinal signs of inflammation

A
  1. Rubor
  2. Calor
  3. Tumor
  4. Dolor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Steps in acute inflammation

A
  1. Blood vessel changes to increase flow
  2. Microvascular changes to allow protein/cells to leave vessels (PMNs = hallmark inflam. cell)
  3. Emigration, accumulation, activation of leukocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute inflammation blood vessel changes

A
  • Dilation due to resident macrophage mediator release
  • Causes edema, cell recruitment, hyperemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

General characteristics of inflammatory mediators

A
  1. Stim. other cells to release secondary effectors and amplify/oppose a given response
  2. Very quickly destroyed or removed; limited time/space activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Types of vasodilators

A
  1. Vasoactive amines
  2. Arachidonic acids from COX enzymes
  3. NO
  4. Bradykinin
  5. Platelet Activating Factor (PAF)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vasoactive amines

A

Histamine, serotonin
- Earliest mediators (preformed granules)
- Release by mast cells + platelets
- Stim. by physical injury, Ab binding to mast cells, complement fragments C3a, C5a
- Cause arteriole dilation/increased permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Arachidonic acid metabolies

A

Prostaglandins, leukotrienes, lipoxins
- From PLs in cell membrane (phospholipase A2 releases AAcids)
- From COX enzyme (prostaglandins, thromboxane; aspirin inhib. COX)
- From 5-lipoxygenase (leukotrienes, lipoxins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Platelet Activating Factor

A
  • From membrane PLs
  • Created by leukocytes, mast cells, endothelial cells, platelets
    Effects:
  • Platelet aggregation
  • Vasodilation @ low levels
  • Leukocyte oxi. burst, adhesion, chemotaxis, degranulation
17
Q

Nitric oxide

A
  • Relaxes smooth muscle to cause vasodilation
  • Bacterial killing
  • From NO synthetase
18
Q

Plasma protein inflammatory mediators

A
  • Activated by cleavage e.g. bradykinin by kallikrein cleavage
19
Q

Microvascular changes that allow proteins/cells out of vessels

A

Endothelial cell retraction (histamine, PGs, NO, bradykinin; dual effect w/ vasodilation)

20
Q

Complement

A
  • Soluble proteins + receptors present in larger inactive forms
  • Cleavage activation by classical, alternative, lectin paths
  • MAC lysis, C3b opsonization, C5a/C3a inflam./leukocytes
21
Q

Complement actions

A

C3a, C5a anaphylatoxins:
- Histamine mast cell release
- Vasodilation, permeability
C5a:
- Chemotaxis esp. PMNs
- Activate lipoxygenase for AraAs
C3b:
- Opsonization

22
Q

Transudate

A

Fluid leaving vessels due to hydrodynamics, low in cells/protein content

23
Q

Exudate

A

Fluid escaping vessels due to inflam.; high cell/protein content

24
Q

Effusion

A

Escape of fluid to defined cavity; drainable

25
Q

Edema

A

Fluid in alveolus/tissue interstitum

26
Q

Types of exudates

A
  1. Serous (few cells, clear)
  2. Purulent (pus; many inflam. cells)
  3. Hemorrhagic (RBCs, capillary dmg)
  4. Fibrinous (fibrin layer deposition)
27
Q

Leukocyte migration across vessel wall process

A

Dilation slows blood, allowing margination
1. Margination when dilation occurs
2. Rolling (selectins, integrins)
3. Tight adhesion (integrins)
4. Extravasation across wall

28
Q

Neutrophil chemotactic factors

A
  • IL-8 CXC chemokines, C5a, PAMPs, PAF, leukotriene B4 (LTB4)
  • Attracts PMNs to site of inflam.
  • Also important for lymph node T/B migration
29
Q

Systemic effects of acute inflammation

A
  1. Fever (cytokines to hypothalamic thermoregulatory center)
  2. Leukocytosis (colony-stim. factors to bone marrow for leukocyte release)
  3. Tachycardia, tachypnea
  4. Acute phase reactants (IL-6 to liver protein synth.
30
Q

2 important functions of acute inflammation

A
  1. Recognize
  2. Remove
31
Q

Types of bacterial killing by phagocytic cells

A
  1. EC traps
  2. IC killing (phagocytosis, engulfment, killing/degradation)
32
Q

EC traps for bacterial killing

A

Neutrophil NETs (chromatin/protein strands)

33
Q

Opsins

A

Bind to pathogens to target for destruction; complement + ABs

34
Q

Phagocytosis process

A
  1. Recognition w/ phagocyte receptors
  2. Engulfment (phagosome creation)
  3. Degradation (phagolysosome; phagocyte oxidase activation)
35
Q

Phagocyte oxidase

A

Activation triggers oxidative burst reaction for ROS generation:
- Superoxide
- H2O2
- OH-
- OONO- (peroxinitrite)

36
Q

Detrimental effects of inflammation

A

Tissue injury due to overinflam.
- ROS/protease release
- Inappropriate coagulation